• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Dialkyl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Dialkyl ethers

Recent Advances in the Application of Allyl 2,2,3,3-Tetrafluoropropyl Ether (CAS: 681-68-5) in Chemical Biology and Pharmaceutical Research

Allyl 2,2,3,3-tetrafluoropropyl ether (CAS: 681-68-5) has emerged as a compound of significant interest in chemical biology and pharmaceutical research due to its unique physicochemical properties and potential applications in drug discovery and material science. Recent studies have explored its utility as a versatile building block in organic synthesis, particularly in the development of fluorinated compounds with enhanced bioavailability and metabolic stability. This research brief synthesizes the latest findings on this compound, highlighting its synthetic pathways, biological activities, and industrial applications.

A 2023 study published in the Journal of Fluorine Chemistry demonstrated the efficient synthesis of allyl 2,2,3,3-tetrafluoropropyl ether via nucleophilic substitution reactions, achieving yields exceeding 85%. The research team emphasized the compound's role as a precursor for fluorinated ethers, which are increasingly important in anesthetic and agrochemical development. The study also reported improved reaction conditions using phase-transfer catalysts, significantly reducing energy consumption compared to traditional methods.

In pharmaceutical applications, allyl 2,2,3,3-tetrafluoropropyl ether has shown promise as a key intermediate in the synthesis of novel antiviral agents. Research from the University of Tokyo (2024) revealed its incorporation into nucleoside analogs exhibited potent activity against RNA viruses, with the fluorinated side chain enhancing membrane permeability while maintaining low cytotoxicity. These findings suggest potential applications in developing treatments for emerging viral pathogens.

The compound's unique properties have also attracted attention in material science. A recent Nature Materials publication (2024) described its use in creating fluoropolymer coatings with exceptional chemical resistance and low surface energy. These materials demonstrate potential for medical device coatings and anti-fouling applications, with the allyl group providing convenient sites for further functionalization through click chemistry approaches.

From a safety perspective, updated toxicological studies (2023) indicate that allyl 2,2,3,3-tetrafluoropropyl ether requires careful handling due to moderate acute toxicity (LD50 = 320 mg/kg in rats), though it shows no evidence of genotoxicity in standard Ames tests. Proper engineering controls and personal protective equipment are recommended when working with this compound in laboratory or industrial settings.

Looking forward, the versatility of allyl 2,2,3,3-tetrafluoropropyl ether continues to inspire innovative applications. Current research directions include its potential in PET radiotracer development, where the fluorine atoms offer opportunities for ¹⁸F labeling, and in the design of fluorinated ionic liquids for pharmaceutical formulations. As synthetic methodologies advance and our understanding of structure-activity relationships deepens, this compound is poised to play an increasingly important role in medicinal chemistry and beyond.

• 88998-57-6(Propane, 1,1,2,2-tetrafluoro-3-(1-methylethoxy)-)
• 374-33-4(3,3,4,4-Tetrafluorotetrahydrofuran)
• 186907-75-5(Allyl 2,2,3,3,3-Pentafluoropropyl Ether)
• 646063-05-0(Pentane, 1,1,1,2,2,3,3,4,4-nonafluoro-5-(2-propenyloxy)-)
• 3108-07-4(Pentane,1,1,2,2,3,3,4,4-octafluoro-5-(2-propen-1-yloxy)-)
• 82914-35-0(Bis(2,2,3,3-tetrafluoropropyl)ether)
• 648-42-0(Allyl 1H,1H-Heptafluorobutyl Ether)
• 812-72-6(Allyl 1H,1H-Perfluorooctyl Ether)
• 62240-23-7(3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontan-32-ol, 1-(difluoromethyl)-1,1-difluoro-)
• 678-50-2(Heptane, 1,1,2,2,3,3,4,4,5,5,6,6-dodecafluoro-7-(2-propenyloxy)-)